Dopamine Transporter Gene Polymorphism and Psychiatric Symptoms Seen in Schizophrenic Patients at Their First Episode

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 67, Issue 4, 1996, Pages 406-408

  Inada, Toshiya ^a   Sugita, Tetsuyoshi ^a,b   Dobashi, Izumi ^a   Inagaki, Ataru ^c   Kitao, Yoshie ^a   Matsuda, Genichi ^d   Kato, Shingo ^b   Takano, Toshiya ^b   Yagi, Gohei ^b   Asai, Masahiro ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c Yamanashi Prefectural Kita Hospital   (Japan)

^d National Psychiatric Institute   (Japan)

Author keywords

Bizarre behavior; Delusion; Disorganization; Hallucination; Negative symptoms

Indexed keywords

ALLELE; ARTICLE; DELUSION; DISORIENTATION; DOPAMINERGIC TRANSMISSION; FREQUENCY ANALYSIS; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HALLUCINATION; HEREDITY; HUMAN; HUMAN CELL; NEGATIVE SYNDROME; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; DELUSIONS; DNA; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; HALLUCINATIONS; HUMANS; JAPAN; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MINISATELLITE REPEATS; NERVE TISSUE PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; REFERENCE VALUES; SCHIZOPHRENIA; SCHIZOPHRENIA, PARANOID; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0029835642     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19960726)67:4<406::AID-AJMG15>3.0.CO;2-N     Document Type: Article

References (12)

1. Andreasen NC (1982): Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry 39:784-788.
2. Andreasen NC (1984): Scale for the assessment of positive symptoms (SAPS). Iowa City, IA: University of Iowa.
3. Byerley W, Coon H, Hoff M, Holik J, Waldo M, Freedman R, Caron MG, Giros B (1993): Human dopamine transporter gene not linked to schizophrenia in multigenerational pedigrees. Hum Hered 43:319-322.
4. Gelernter J, Kranzler HR, Satel SL, Rao PA (1994): Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 11:195-200.
5. Inada T, Polk K, Purser C, Hume A, Hoskins B, Ho IK, Rockhold RW (1992): Behavioral and neurochemical effects of continuous infusion of cocaine in rats. Neuropharmacology 31:701-708.
6. Iyo M, Maeda Y, Inada T, Kitao Y, Sasaki H, Fukui S (1995): The effects of a selective cAMP phosphodiesterase inhibitor, rolipram, on methamphetamine-induced behavior. Neuropsychopharmacology 13:33-39.
7. Li T, Yang L, Wiese C, Xu CT, Zeng Z, Giros B, Caron MG, Moises HW, Liu X (1993): No association between alleles or genotypes at the dopamine transporter gene and schizophrenia. Psychiatry Res 52: 17-23.
8. Peralta V, de Leon J, Cuesta MJ (1992): Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy. Br J Psychiatry 161:335-343.
9. Persico AM, Vandenbergh DJ, Smith SS, Uhl GR (1993): Dopamine transporter gene polymorphisms are not associated with polysubstance abuse. Biol Psychiatry 34:265-267.
10. Persico AM, Wang ZW, Black DW, Andreasen NC, Uhl GR, Crowe RR (1995): Exclusion of close linkage of the dopamine transporter gene with schizophrenia spectrum disorders. Am J Psychiatry 152: 134-136.
11. Sano A, Kondoh K, Kakimoto Y, Kondo I (1993): A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum Genet 91:405-406.
12. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR (1992): Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14: 1104-1106.